| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a14c3b5a4e1f34cfb2066f09583655cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0100c26dd0a54a962583a7e1a37b8f9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ddde905e0055ab1a38be9d327e143b75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_546e9ccf59572045315cad7760e24500
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_674fc9bcc1f27d7c099c9038ae5974de |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d660cfae263ce2ff44d036bd5f1abb27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d6e666195975a5d657945837acff11d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd301e50a91c3e097208eb25a864e623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8a757f82a717c4ddb2087edf4eff804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93760fbfdbd902097732ec64dbfd7e8a |
| publicationDate |
2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03042370-A2 |
| titleOfInvention |
New gene expressed in prostate cancer and methods of use |
| abstract |
A new polypeptide is disclosed that is specifically detected in the cells of the prostate, termed Novel Gene Expressed in Prostate (NGEP). Polynucleotides encoding NGEP are also disclosed, as are vectors including these polynucleotides. Host cells transformed with these polynucleotides are also disclosed. Antibodies are disclosed that specifically bind NGEP. Methods are disclosed for using an NGEP polypeptide, an antibody that specifically binds NGEP, or a polynucleotide encoding NGEP. Assays are disclosed for the detection prostate cancer. Pharmaceutical compositions including an NGEP polypeptide, an antibody that specifically binds NGEP, or a polynucleotide encoding NGEP are also disclosed. These pharmaceutical compositions are of use in the treatment of prostate cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004092213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7572887-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8748390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03042370-A3 |
| priorityDate |
2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |